Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Nov 24.
Published in final edited form as: Bull Korean Chem Soc. 2005 Oct 20;26(10):1503–1504. doi: 10.5012/bkcs.2005.26.10.1503

New Synthetic Approach to the Bicyclo[3.1.0]hexane Ring System from (+)-(1R,4R)-4-(Benzyloxymethyl)-4-(hydroxymethyl)cyclopent-2-enol

Soon-Ai Kim *, Kenneth A Jacobson , Hak Sung Kim †,*
PMCID: PMC8611652  NIHMSID: NIHMS1756403  PMID: 34824486

A methanocarba approach to conformationally constrain the sugar ring in nucleosides and nucleotides was introduced by Marquez and co-workers.1 Thus, a bicyclo[3.1.0]hexane system has been constrained in a North ((N), 2'-exo) or South ((S), 2'-endo) conformation, according to the pseudo-rotational cycle. In many studies of the ribose ring conformation of nucleosides and nucleotides binding to G protein-coupled receptors (GPCRs), novel (N)-ligands for adenosine receptors2 and P2Y receptors3 provided favorable receptor affinity and/or selectivity compared to their corresponding (S)-conformers. In addition, (N)-bicyclo[3.1.0]hexane nucleosides, -tides and oligonucleotides, including 2'-deoxy analogues, were good candidates for the development of a potent antiherpes agent,4 as an inhibitor of (cytosine C5)-methyltransferase, for using in oligonucleotides5 and as a mechanistic probe of base flipping by Hhal DNA methyltransferase.6

Since the biological relevance of (N)-bicyclo[3.1.0]-hexane derivatives is so high, additional effort is warranted to overcome the drawbacks of the previous synthetic pathways described in earlier publications.7,8 Those methods involved two or three operationally demanding steps and gave unexpectedly low yields when applied to a gram-scale synthesis (Figure 1). The preparation of (N)-bicyclo[3.1.0]-hexanes in quantity is crucial to progress in the related research fields; thus, improving the yield of existing synthetic steps or developing novel synthetic pathways is desirable. In this letter we describe the conversion of (+)-(1R,4R)-4-(benzyloxymethyl)-4-(hydroxymethyl)cyclopent-2-enol into a key intermediate (+)-bicyclo[3.1.0]hexane alcohol 1. The starting material 2 contains a quaternary carbon, which eliminates the need for harsh conditions usually associated with the construction of a quaternary carbon center. Although there remain aspects for further refinement, this work provides a novel route to obtain the crucial intermediate (+)-bicyclo[3.1.0]hexane 1.

Figure 1.

Figure 1.

Two previous synthetic routes to the bicyclo[3.1.0] hexane system and its application to various nucleosides and nucleotides.

The synthesis of (+)-(1R,4R)-4-(benzyloxymethyl)-4-(hydroxymethyl)cyclopent-2-enol 2 was done according to the previously reported method.9 The versatility of diol 2 was demonstrated previously with the synthesis of the (N)-locked bicyclo[2.2.1]heptane system.10 Preparation of silyl acetonide 3 from 2 followed a well-established method.10 The published report10 gave a synthetic method to a silyl triol, which was protected as the acetonide to afford silyl acetonide 3 (Scheme 1). Removal of the benzyl group with Pd/C in the presence of hydrogen in a variety of conditions was also accompanied by the unexpected deprotection of the silyl group. Treatment of silylated acetonide 3 with Pd black and formic acid11 as a substitute for hydrogen gas accomplished the requisite debenzylation without desilylation, along with the unexpected deprotection of the acetonide group. The resulting tetraol was in situ protected to give the silyl diacetonide 4 in 73% yield for two steps. After the acetonide moiety on the 1,3-diol group of 4 was selectively removed in 87% yield by treatment with catalytic pyridinium p-toluenesulfonate12 in methanol at room temperature, benzylation (BnBr, t-BuOK in THF) of the resulting 1,3-diol was attempted. Initially, it was thought that steric hindrance induced by the concave bicyclo[3.3.0]octane system would favor benzylation at the convex face over the concave. However, the resulting selectivity on benzylation was barely evident, since the ratio of 5 : 6 was found to be 1 : 1.2 based on integration of the proton NMR spectra. It is pertinent to mention here that selective benzylation or selective protection of the 1,3-diol remains a challenge for future study and is currently in progress in our lab. Fortunately, 5 and 6 were readily separated by column chromatography on silica gel. The requisite alcohol 6 was mesylated by upon treatment with methanesulfonyl chloride and TEA, followed by desilylation with TBAF to give the hydroxy mesylate 713 in 71% yield for two steps. Oxidation of the hydroxyl group of 7 was accomplished using an excess of PDC in dichloromethane at room temperature to furnish the mesyl ketone 814 in 84% yield, which is readily decomposed in strong basic condition or prolonged, elevated temperature. The decomposition appeared to be caused by elimination of the acetonide, which was confirmed by the disappearance of the two methyl peaks of the acetonide group in the proton NMR spectrum. However, the stability of 8 during the PDC oxidation at room temperature and the subsequent chromatography was satisfactory. Intramolecular cyclization15 of mesyl ketone 8 was performed by treatment with exactly one equivalent of t-BuOK in THF at −50 °C for 10 min to furnish 9 in 75% yield.16 The final conversion of bicyclic ketone 9 into 1 was accomplished in 97% yield by reduction of the ketone group with NaBH4. The structure of 1 was confirmed by comparison with the proton NMR spectrum and optical rotation ([α] = +70.7, c = 0.03, in chloroform, 25 °C, yellow sodium D line) of the original compound 11d ([α] = +67.3, c = 0.27), synthesized from D-(+)-ribono-γ-lactone.ld

Scheme 1.

Scheme 1.

i) cat. PTSA, acetone, rt, 3 h, 95%. ii) Pd black, HCO2H, MeOH, 60 °C, 2 h, and then cat. PTSA, acetone, rt, 5 h, 73% two steps yield. iii) cat. pyr·TsOH, MeOH, rt, 1 h, 87%. iv) BnBr, tBuOK, THF, 0 °C – rt,’ 5 (36%), 6 (43%). v) MsCl, TEA, −10 °C – rt, 30 min. vi) TBAF, THF, rt, overnight, 71% two steps yield. vii) excess PDC, CH2Cl2, rt, overnight, 84%. viii) t-BuOK, THF, −20 °C, 75%. ix) NaBH4, MeOH, 0 °C, 10 min, 97%.

In summary, we have developed a new synthetic route to a versatile intermediate 1, a key building block for the preparation of nucleosides and nucleotides containing the bicyclo[3.1.0]hexane system from a readily available starting material 2. In this case, the preformed quaternary carbon center facilitated synthetic manipulation. The new procedure should allow us to make 1 in multigram scale, which in turn will facilitate the synthesis receptor probes and other biologically important bicyclo[3.1.0]hexane derivatives. Overcoming the lack of sufficient quantities of the crucial intermediate 1 should advance the biological investigation of this class of compounds. By the same token, synthetic work leading to 1 or the related 2'-deoxybicyclo[3.1.0] system is currently underway in our lab.

Acknowledgement.

This work was supported by Korea Research Foundation Grant (KRF-2004-002-E00207).

Contributor Information

Soon-Ai Kim, College of Pharmacy, Wonkwang University, Iksan, Jeonbuk 570-749, Korea..

Hak Sung Kim, College of Pharmacy, Wonkwang University, Iksan, Jeonbuk 570-749, Korea.

References

  • 1. (a).Rodriguez JB: Marquez VE; Nicklaus MC; Mitsuya H; Barchi JJJ Jr. Med. Chem 1994, 37, 3389. [DOI] [PubMed] [Google Scholar]; (b) Marquez VE; Siddiqui MA; Ezzitouni A; Russ P; Wang J; Wagner RW; Matteucci MD J. Med. Chem 1996, 39, 3739. [DOI] [PubMed] [Google Scholar]; (c) Marquez VE; Ezzitouni A; Russ P; Siddiqui MA; Ford H Jr.; Feldman RJ; Mitsuya H; George C; Barchi JJ Jr. J. Am. Chem. Soc 1998, 120, 2780. [Google Scholar]; (d) Jeong LS; Buenger GJ; McCormack J; Cooney DA; Hao Z; Marquez VE J. Med. Chem 1998, 41, 2572. [DOI] [PubMed] [Google Scholar]; (e) Moon HR; Kim HO; Chum MW; Jeong LS; Marquez VE J. Org. Chem 1999, 63, 4733. [DOI] [PubMed] [Google Scholar]; (f) Joshi BV; Marquez VE; Fettinger JC; Jacobson KA Abstracts of Papers, 227th ACS National Meeting, Anaheim, CA, USA, 2004; MEDI-256. [Google Scholar]
  • 2.Jacobson KA; Ji X-D; Li AH; Melman N; Siddiqui MA; Shin KJ; Marquez VE; Ravi RG J. Med. Chem 2000, 43, 2196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Nandanan E; Jang SY; Moro S; Kim HO; Siddiqui MA; Russ P; Marquez VE; Busson R; Herdewijn P; Harden TK; Boyer JL; Jacobson KA J. Med. Chem 2000, 43, 829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Russ R; Schelling P; Scapozza L; Folkers G; De Clercq E; Marquez VE J. Med. Chem 2003, 46, 5045. [DOI] [PubMed] [Google Scholar]
  • 5.Marquez VE; Wang P; Nicklaus MC; Maier M; Manoharan M; Christman JK; Banavali NK; Mackerell AD Jr. Nucleosides, Nucleotides & Nucleic Acids 2001, 20, 451. [DOI] [PubMed] [Google Scholar]
  • 6.Wang P; Brank AS; Banavali NK; Nicklaus MC; Marquez VE; Christman JK; Mackerell AD Jr. J. Am. Chem. Soc 2000, 122, 12422. [Google Scholar]
  • 7.Marquez VE; Lim MI; Christopher KHT; Markovac A; Matthew AP; Khan MS; Kaskar B J. Org. Chem 1988, 53, 5709. [Google Scholar]
  • 8.Lee K; Cass C; Jacobson KA Org. Lett 2001, 3, 597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hodgson DM; Gibbs AR; Drew MGB J. Chem. Soc., Perkin Trans 1 1999, 24, 3579. [Google Scholar]
  • 10.Kim HS; Jacobson KA Org. Lett 2003, 5, 1665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.ElAmin B, Anantharamaiah GM; Royer PP; Means GE J. Org. Chem 1979, 44, 3442. [Google Scholar]
  • 12.Van Rijsbergen R; Anteunis MJO; De Bruyn AJ Carbohydr. Chem 1986, 51, 404. [Google Scholar]
  • 13.Proton NMR spectrum for 7. 1H NMR (500 MHz, CDCl3) σ7.26-7.40 (m, 5H), 4.57 (s, 2H), 4.50 (AB quartet, 2H, J = 4.5 Hz), 4.29 (d, 1H, J = 9.2 Hz), 4.13 (d, 1H, J = 9.2 Hz), 4.11 (m, 1H), 3.66 (d, 1H, J = 9.2 Hz), 3.57 (d, 1H, J = 9.2 Hz), 2.98 (s, 3H), 2.06 (dd, 1H, J = 6.4, 14.7 Hz), 1.69 (d, 1H, J = 14.7 Hz), 1.42 (s, 3H), 1.26 (s, 3H)
  • 14.Proton NMR spectrum for 8. 1H NMR (500 MHz, CDCl3) δ7.18-7.37 (m, 5H), 4.57 (d, 1H, J = 4.5 Hz), 4.47 (AB quartet, 2H, J = 11.1 Hz), 4.40 (d, 1H, J = 10.0 Hz), 4.40 (m, 1H), 4.29 (d, 1H, J = 10.0 Hz), 3.66 (d, 1H, J = 9.0 Hz), 3.44 (d, 1H, J = 9.0 Hz), 2.57 (s, 3H), 2.44 (d, 1H, J = 17.5 Hz), 2.22 (d, 1H, J = 17.5 Hz), 1.42 (s, 3H), 1.32 (s, 3H)
  • 15.Kojima K; Amemiya S; Saito S Chem. Pharm. Bull 1987, 35, 948. [DOI] [PubMed] [Google Scholar]
  • 16.Proton NMR spectrum for 9. 1H NMR (500 MHz, CDCl3) σ7.27-7.38 (m, 5H), 5.08 (dd, 1H, J = 1.8, 8.3 Hz), 4.59 (d, 1H, J = 12.4 Hz, one of two benzylic protons), 4.53 (d, 1H, J = 12.4 Hz, one of two benzylic protons), 4.23 (dd, 1H, J = 1.4, 7.8 Hz), 3.80 (d, 1H, J = 10.5 Hz), 3.34 (d, 1H, J = 10.5 Hz), 2.04 (ddd, 1H, J = 1.8, 4.1, 10.1 Hz), 1.64 (dd, 1H, J = 4.1, 5.0 Hz), 1.53 (s, 3H), 1.31 (m, 1H), 1.30 (s, 3H); 13C NMR (100 MHz, CDCl3) σ204.85, 137.83, 128.61 (two carbons on phenyl ring), 128.00, 127.86 (two carbons on phenyl ring), 114.80, 79.53, 73.25, 71.06, 36.52, 36.15, 25.75, 24.20, 16.64

RESOURCES